Naim Farhat, MD
Interventional Cardiology · Elyria, OHNPI 1881673234
Payments from drug & device makers
Across 247 payments — averaging $3591.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$700K
- CSL Behring$165K
- Medtronic$9K
- Abbott$7K
- Surmodics, Inc.$3K
- Abiomed$556
- plus $2K from 23 others
Across 2 payments — averaging $2000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Philips North America LLC$4K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 34 | $699,921 |
| CSL Behring | 94 | $165,307 |
| Medtronic(2 entities) | 40 | $9,319 |
| Abbott | 13 | $6,866 |
| Surmodics, Inc. | 4 | $3,309 |
| Abiomed | 4 | $556 |
| Atricure, Inc. | 8 | $454 |
| W. L. Gore & Associates, Inc. | 1 | $450 |
| Novartis | 10 | $163 |
| E.r. Squibb & Sons, L.L.C. | 6 | $111 |
| Heartflow, Inc. | 1 | $108 |
| AstraZeneca | 3 | $61 |
| Johnson & Johnson | 4 | $58 |
| Pfizer | 4 | $48 |
| Boehringer Ingelheim | 3 | $48 |
| Gilead | 2 | $44 |
| Cardiovascular Systems Inc. | 2 | $40 |
| Cardiva Medical, Inc. | 2 | $38 |
| Novo Nordisk | 2 | $31 |
| Lexicon Pharmaceuticals, Inc. | 1 | $30 |
| Esperion Therapeutics, Inc. | 1 | $22 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $22 |
| Lundbeck LLC | 1 | $17 |
| Cordis US CORP. | 1 | $16 |
| Boston Scientific | 1 | $15 |
| Philips North America LLC | 1 | $15 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
| Terumo Medical Corporation | 1 | $13 |
| Z-medica, LLC | 1 | $9 |
How this compares
$887,103 in reported general payments places this provider in the 95th percentile of 256 interventional cardiology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Elyria
- Santiago GarciaCincinnati$3.6M
- Gary AnselColumbus$3.4M
- Dean KereiakesCincinnati$3.4M
- Steven YakubovColumbus$3.2M
- Joseph ChooCincinnati$1.9M
- Carlos Sanchez SotoColumbus$1.7M
- John CheathamColumbus$1.7M
- Brendan DuffyCanton$1.5M
- Timothy HenryCincinnati$1.3M
- Gary FishbeinCenterville$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.